India's First Dengue Vaccine 'Qdenga' to Launch in 2027—How It Works

CDSCO-approved Qdenga (TAK-003), a two-dose vaccine for ages 4-60, protects against all four dengue serotypes using a live-attenuated DENV-2 backbone. Developed by Takeda, distributed by Dr Reddy's, it'll hit India's private market in early 2027—no prior infection screening needed.